Literature DB >> 11197052

Chronic hepatitis C is mild in menstruating women.

M Sartori1, S Andorno, C Rigamonti, E Grossini, G Nicosia, R Boldorini.   

Abstract

BACKGROUND AND AIMS: Women with chronic hepatitis C may have a slower rate of disease progression than men. We have previously demonstrated a relationship between hepatic iron concentration and liver fibrosis in patients with chronic hepatitis C. Our aim was to compare hepatic histologic findings, iron status and other factors putatively capable of determining the severity of chronic hepatitis between menstruating women and men of comparable age.
METHODS: We studied 21 consecutive hepatitis C virus (HCV)-RNA positive menstruating women and 24 consecutive HCV-RNA positive men of comparable age, who underwent liver biopsy for chronic hepatitis C. Alcohol intake was recorded and blood tests, HCV genotyping, serum iron, unsaturated iron binding capacity, serum ferritin, hepatic iron concentration, and liver histology were evaluated.
RESULTS: Menstruating women showed lower grading (2.7 +/- 1.5 vs 3.6 +/- 2, P = 0.09) and significantly lower staging (1.38 +/- 1.11 vs 2.42 +/- 1.64, P = 0.037) scores than men of comparable age. Among the factors putatively capable of determining the severity of chronic hepatitis, only the hepatic iron concentration correlated with the hepatic histologic staging in a multivariate analysis. Iron-depleted women (transferrin saturation < 20% and/or serum ferritin < 9 micrograms/L) showed significant lower hepatic histologic grading (1.75 +/- 0.7 vs 3.23 +/- 1.55, P = 0.027) and staging (0.75 +/- 1.03 vs 1.77 +/- 1.01, P = 0.026) scores than women with normal iron status.
CONCLUSIONS: Menstruating women with chronic hepatitis C may have a milder disease compared to men of comparable age, possibly because of menstrual blood loss and lower hepatic iron concentration. Women with chronic hepatitis C and iron deficiency have a milder disease compared to women with normal iron status, suggesting that iron deficiency results in a slower rate of disease progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11197052     DOI: 10.1046/j.1440-1746.2000.02368.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.

Authors:  Joy Baseke; Monica Musenero; Harriet Mayanja-Kizza
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

2.  Gender-related variations in iron metabolism and liver diseases.

Authors:  Duygu D Harrison-Findik
Journal:  World J Hepatol       Date:  2010-08-27

3.  Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.

Authors:  Massimo Sartori; Silvano Andorno; Michela Pagliarulo; Cristina Rigamonti; Cristina Bozzola; Patrizia Pergolini; Roberta Rolla; Anna Suno; Renzo Boldorini; Giorgio Bellomo; Emanuele Albano
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

4.  Phlebotomy improves histology in chronic hepatitis C males with mild iron overload.

Authors:  Massimo Sartori; Silvano Andorno; Angelo Rossini; Renzo Boldorini; Cristina Bozzola; Stefania Carmagnola; Mario Del Piano; Emanuele Albano
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

5.  Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads.

Authors:  Hitomi Sezaki; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Yoshiyuki Suzuki; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2008-10-28       Impact factor: 3.199

6.  Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C.

Authors:  Naoki Fujita; Yoshiyuki Takei
Journal:  J Gastroenterol       Date:  2007-11       Impact factor: 7.527

7.  Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease.

Authors:  Gil Peretz; Gabriela Link; Orit Pappo; Rafael Bruck; Zvi Ackerman
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.